LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Inicio・Lista de Acciones・Pfizer

Pfizer

Abierto

Sector Salud

29.82 1.91

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

29.26

Máximo

29.88

Métricas clave
By Trading Economics
Ingresos	-3.1B 41M
Ventas	-1.6B 13B
P/B Media del Sector	15.73 103.001
BPA	0.6
Margen de beneficio	0.308
Empleados	88,000
EBITDA	-3.5B 2.4B

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+11.96 upside

Dividendos
By Dow Jones
Próximas Ganancias	29 oct 2024
Fecha Próximo Dividendo	2 dic 2024
Próxima Fecha de Ex Dividendo	7 nov 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	164B
Apertura anterior	27.91
Cierre anterior	29.82

Noticias sobre sentimiento de mercado

By Acuity

68%

32%

311 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

29.19 / 29.74 Soporte y Resistencia

Pfizer Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

3 sept 2024, 10:28 UTC

Ganancias

Pfizer, Valneva Report Positive Lyme Disease Vaccine Candidate Data

12 sept 2024, 17:01 UTC

Principales Noticias

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- Update

12 sept 2024, 11:00 UTC

Principales Noticias

The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ

12 sept 2024, 10:00 UTC

Principales Noticias

Moderna Pulls Back on R&D and Delays Timeline for Profitability -- Barrons.com

6 sept 2024, 11:00 UTC

Principales Noticias

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3 sept 2024, 17:22 UTC

Principales Noticias

Pfizer Better Watch Out for This Biotech -- Heard on the Street-- WSJ

3 sept 2024, 10:31 UTC

Charlas de Mercado

Valneva Shares Gain on Positive Vaccine News -- Market Talk

23 ago 2024, 18:38 UTC

Principales Noticias

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

19 ago 2024, 09:30 UTC

Principales Noticias

Adquisiciones, fusiones, absorciones

Pfizer Is Staking Its Turnaround on Cancer Drugs -- WSJ

8 ago 2024, 10:30 UTC

Principales Noticias

Big Pharma Cuts R&D, Sending Shudders Through Industry -- Heard on the Street -- WSJ

1 ago 2024, 15:56 UTC

Ganancias

Merck Created the World's Biggest Drug. Now It -2-

1 ago 2024, 15:56 UTC

Ganancias

Merck Created the World's Biggest Drug. Now It Has to Replace It. -- Barrons.com

1 ago 2024, 10:30 UTC

Principales Noticias

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

30 jul 2024, 17:18 UTC

Ganancias

Pfizer Raises Outlook Amid Strong Demand for Non-Covid Products -- WSJ

30 jul 2024, 15:53 UTC

Ganancias

Nasdaq Dives As Microsoft Earnings Loom; Two Dow Jones Leaders Crater On Earnings (Live Updates) -- IBD

30 jul 2024, 15:52 UTC

Principales Noticias

Heard on the Street: Pfizer Finally Gets Past Covid -- WSJ

30 jul 2024, 11:37 UTC

Ganancias

Pfizer Stock Rises After Guidance Hike, Earnings Beat. -- Barrons.com

30 jul 2024, 11:18 UTC

Principales Noticias

Ganancias

Pfizer Stock Rises After Drug Maker Raises Outlook -- WSJ

30 jul 2024, 11:12 UTC

Ganancias

Pfizer Stock Rises On Earnings Beat, Raised Outlook -- IBD

30 jul 2024, 11:01 UTC

Ganancias

Pfizer's Stock Pops After Earnings Beat As Company Raises Guidance And Unveils Cost Cuts -- MarketWatch

30 jul 2024, 10:50 UTC

Ganancias

Pfizer: Current Guidance Doesn't Anticipate Any Share Repurchases in 2024 >PFE

30 jul 2024, 10:49 UTC

Ganancias

Pfizer Sees 2024 Adjusted R&D Expenses $11B-$12B >PFE

30 jul 2024, 10:49 UTC

Ganancias

Pfizer Had Seen 2024 Adjusted EPS $2.15-$2.35 >PFE

30 jul 2024, 10:48 UTC

Ganancias

Pfizer Now Sees 2024 Operational Rev Growth of 9%-11%; Had Seen 8%-10% >PFE

30 jul 2024, 10:47 UTC

Ganancias

Pfizer Raises 2024 View To Adj EPS $2.45-Adj EPS $2.65 >PFE

30 jul 2024, 10:47 UTC

Ganancias

Pfizer Raises 2024 View To Rev $59.5B-$62.5B >PFE

30 jul 2024, 10:47 UTC

Ganancias

Pfizer 2Q Biopharma Revenue $12.99B, Up 2% >PFE

30 jul 2024, 10:46 UTC

Ganancias

Pfizer: On Track for at Least $4B Net Cost Savings by End 2024 From Cost-Realignment Program >PFE

30 jul 2024, 10:45 UTC

Ganancias

Pfizer Posts $1.3B 2Q Costs for Manufacturing Optimization Program >PFE

30 jul 2024, 10:45 UTC

Ganancias

Pfizer Raises 2024 Guidance >PFE

Comparación entre iguales

Cambio de precio

Pfizer Esperado

Precio Objetivo

By TipRanks

11.96% repunte

Estimación a 12 meses

Media 32.77 USD 11.96%

Máximo 45 USD

Mínimo 27 USD

De acuerdo con 18 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Pfizer Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

18 ratings

Comprar

Mantener

Vender

De acuerdo con 18 analistas que ofrecen calificaciones bursátiles a para Pfizer Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

29.19 / 29.74Soporte y Resistencia

Bullish events outweigh bearish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentimiento

By Acuity

311 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Pfizer

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.